Abstract:Aim: To observe the levels of C-reactive protein (CRP) and interleukin-6 (IL-6) in the newly onset type 2 diabetics and the effects of glucose control on CRP and IL-6. Methods: (1) Forty-eight newly onset type 2 diabetics (22 males and 26 females) in the Department of Endocrinology, Jiangsu Provincial People's Hospital from February to June 2003 were enrolled with the average age of (50±7) years old and body mass index (BMI) of (25.64 ±2.92) kg/m2. Knowing and agreeing with the therapeutic regimen well, all the patients whose diagnosed meeting the criterion of American Diabetes Association (ADA) took the oral hypoglycemia drug complex metformin 0.25-0.5 g, 3 times a day for 3 months to control their blood glucoses. Serum levels of CRP and IL-6 were assayed with chemiluminescence immunometric assay and enzyme linked immunosorbent assay (ELISA), respectively before and after the glucose control. (2) Thirty healthy subjects (13 males and 17 females) on the clinic for health examination of Jiangsu Province Official Hospital worked as controls with the average age of (51 ±7) years old and BMI of (25.06±3.10) kg/m2, fasting blood glucose (FBG) and P2hBG both were in normal range. They all knew the result of identification. Good comparabilities of age, sex, BMI, blood pressure and blood lipid were available in two groups. (3) As both CRP and IL-6 were in positive skewness distribution, the data of CRP and IL-6 were given as median and quartile, analyzed by logarithm. (4) The Student's t test analysis was used in the comparison of groups. Results: All the 48 blood samples of diabetes and 30 controls were obtained and involved in the result analysis. (1) Serum CRP levels in T2DM were (9.89±5.71) mg/L, (6.22±4.19) mg/L respectively, both significantly higher than those in normal control group (2.50±1.40) mg/L (P < 0.01). (2) Serum IL-6 levels in T2DM were (13.33±4.08) ng/L, (7.93±3.26) ng/L, respectively, both remarkably higher than those of normal controls (3.63 ±2.12) ng/L (P < 0.01). (3) Both levels of CRP and IL-6 were markedly decreased in T2DM after treatment with complex metformin following the improvement of hyperglycemia (P < 0.01). Conclusion: (1) Inflammatory factors such as CRP and IL-6 shows abnormality in the newly onset type 2 diabetics. (2) Good glucose control can both significantly decrease levels of CRP and IL-6.

Influence of Metformin on C-reactive Protein in Patients with Type 2 Diabetes Mellitus

Effects of non-surgical periodontal treatment on clinical response, serum inflammatory parameters, and metabolic control in patients with type 2 diabetes: a randomized study.

Association Of Periodontal Parameters With Metabolic Level And Systemic Inflammatory Markers In Patients With Type 2 Diabetes

Association Between Metformin Use and Coronary Artery Calcification in Type 2 Diabetic Patients

C-reactive Protein for Predicting Cardiovascular and All-Cause Mortality in Type 2 Diabetic Patients: A Meta-Analysis

Serum N-3 Polyunsaturated Fatty Acid and High-sensitivity C Reactive Protein in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Effects of glucose control on the levels of C reactive protein and interleukin-6 in patients with newly onset type 2 diabetics

Effect of Metformin on Testosterone Levels in Male Patients With Type 2 Diabetes Mellitus Treated With Insulin

The effect of Metformin on urinary MCP-1 excretion in patients with type 2 diabetes

Clinical Significance of Determination of Serum Cystatin C,lipoprotein (α) and High Sensitivity C-reactive Protein in Type 2 Diabetic Patients with Early Renal Impairment.

Change of Retinol Binding Protein-4 Concentrations in Patients with Type 2 Diabetes Mellitus and Its Relationship with Glucose and Lipid Metabolism

Association between metformin treatment and coronary artery inflammation based on pericoronary adipose tissue attenuation in type 2 diabetes mellitus patients

Effects of DPP-4 Inhibitor Combined with Metformin on Blood Glucose Control,oxidative Stress and Inflammatory Response in Patients with Type 2 Diabetes Mellitus

Effect of metformin on adipose tissue distribution and hepatic lipid content in patients with type 2 diabetes

Effect of intensive insulin therapy on serum inflammatory factors in newly onset diabetic patients

Relationship of Serum C Reactive Protein Level with Serum Leptin Concentration in Type 2 Diabetic Patients

Analysis of the Variation Levels of APN, Insulin, Sensitive C-Reactive Protein and Leptin in the Serum of Patients with Type 2 Diabetes Mellitus

Effects of Rosiglitazone puls metformin on serum high C reaction protein and IL-6 in type 2 diabetes mellitus

Rapid Changes in Serum Testosterone in Men with Newly Diagnosed Type 2 Diabetes with Intensive Insulin and Metformin

Changes in C-reactive Protein in Patients with Type 2 Diabetes after Treatment with Pioglitazone

Effect of Intensive Insulin Therapy on Urinary Intercellular Adhesion Molecule-1 Excretion in Patients with Type 2 Diabetes Mellitus